New-onset Afib is the most common complication after cardiac surgery, and the BoxX-NoAF clincial trial is exploring a proactive approach.
This innovative trial will set out to evaluate if cardiac ablation and left atrial appendage exclusion (LAAE) during cardiac surgery is effective in the prevention of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.
Discover more about the trial here: https://okt.to/KUjVNy
The cryoSPHERE® MAX probe helps surgeons manage post-op pain more efficiently by covering more intercostal space in a single therapeutic cycle.
Discover how: https://okt.to/TAMFlE#cryoNB#PainManagement
Afib and Heart Failure.
Two conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.
Both affect millions of people and after age 40:
1 in 4 people will develop Afib
1 in 5 people will develop HF
And, regardless of which comes first - patients with Afib and HF together have significantly worse prognosis.
Learn more about the impact of heart failure and Afib: https://okt.to/ALk5Hv#HeartFailureWeek#HeartFailure#Afib
Great few days at #AFSymposium26. Together, we discussed the impact of Hybrid AF™ Therapy and the data supporting durable outcomes for patients with advanced Afib. Thank you to everyone who joined us.
Learn more about durable treatment options for your patients: https://okt.to/C2lLSh#Afib#Epeeps#HybridAFTherapy
Women in STEM drive innovation, strengthen our teams, and inspire what we do every day. Hear from our employees on what they love about STEM and their advice for girls exploring science. #WomeninSTEM#GirlsinSTEM#Womeninscience
Some Afib symptoms are subtle—but even mild signs can signal bigger heart risks. This #HeartMonth, don’t ignore your heart. Learn the symptoms and your treatment options: https://okt.to/3YMqXy
#Afib#AfibAwareness
Black History Month is a time to reflect, listen and learn. Our employees share what inclusion, belonging, and cultural celebration mean to them and how AtriCure works to support every team member, every day. #BlackHistoryMonth
In honor of Dr. Martin Luther King Jr., we’re taking time to reflect on his timeless words and the power of service and its ability to transform communities. Doing for others is our greatest mission. #MLKDay
New-onset Afib is the most common complication after cardiac surgery, and the BoxX-NoAF clincial trial is exploring a proactive approach.
Discover more about the trial here: https://t.co/XtJ50uS8yc
The cryoSPHERE® MAX probe helps surgeons manage post-op pain more efficiently by covering more intercostal space in a single therapeutic cycle.
Discover how: https://t.co/SuJyeWCsfr#cryoNB#PainManagement
1 in 4 people will develop Afib, and 1 in 5 people will develop heart failure. Both are conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.
Learn more about the impact of HF and how you can help:
Great few days at #AFSymposium26. Together, we discussed the impact of Hybrid AF™ Therapy and the data supporting durable outcomes for patients with advanced Afib. Thank you to everyone who joined us.
Learn more about durable treatment options for your patients:
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
Kathy's Journey with Long-standing Persistent Afib
Duration: 4:45
Is PFA Effective in the Treatment of Persistent and Long Standing Persistent Atrial Fibrillation
Duration: 21:19
Cryo Nerve Block: A Non-Opioid Solution for Post-op Pain Management
Duration: 3:23
Mike's Story: From 10 Years of Afib to Having His Life Back
Duration: 3:39
social media channels to keep updated on the latest at AtriCure.